[AKRO] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
04-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -27.70%
YoY- -43.83%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -31,083 -25,831 -23,059 -35,542 -27,403 -26,029 -32,424 -2.78%
Tax 6,260 -2,465 -2,574 -549 297 -22 -11 -
NP -31,083 -23,366 -20,485 -34,993 -27,403 -26,007 -32,424 -2.78%
Tax Rate - - - - - - - -
Total Cost 31,083 23,366 20,485 34,993 27,403 26,007 32,424 -2.78%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.60 -0.50 -0.44 -0.91 -0.77 -0.74 -0.93 -25.39%
EPS Diluted -0.60 -0.50 -0.44 -0.91 -0.77 -0.74 -0.93 -25.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.